Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemia | Synapse
March 1, 2026Open Access
Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemia
Key Points
The study aims to trace the clonal origin and analyze biomarkers related to disease progression in a specific patient with JAK2V617F-positive essential thrombocythemia.
Conducted clonal origin tracing
Performed integrated biomarker analysis
Documented disease progression from essential thrombocythemia to T-cell acute lymphoblastic leukemia
Identified clonal lineage transition during progression
Noted significant biomarker changes associated with disease advancement